tiprankstipranks
Trending News
More News >
Vistance Networks (VISN)
NASDAQ:VISN

Vistance Networks (VISN) AI Stock Analysis

Compare
1,130 Followers

Top Page

VISN

Vistance Networks

(NASDAQ:VISN)

Select Model
Select Model
Select Model
Neutral 60 (OpenAI - 4o)
Rating:60Neutral
Price Target:
$20.50
▲(4.70% Upside)
CommScope's overall stock score is driven by strong earnings call performance and positive technical analysis, indicating potential growth and momentum. However, financial performance concerns, particularly high leverage and historical volatility, along with unattractive valuation metrics, weigh down the score.
Positive Factors
Segment Growth
The significant growth in ANS and RUCKUS segments indicates strong demand and effective market positioning, enhancing long-term revenue potential.
Strategic Divestiture
The sale of the CCS business will provide substantial cash inflow, allowing debt reduction and potential shareholder returns, strengthening financial stability.
Improved Financial Guidance
Raising EBITDA guidance reflects confidence in operational performance and market conditions, indicating robust future profitability and business health.
Negative Factors
High Leverage
High leverage and negative equity pose risks to financial flexibility and long-term sustainability, potentially impacting investment and growth capabilities.
Cyclical Segment Risks
Cyclical nature of certain segments can lead to revenue volatility, affecting consistent cash flow and profitability, challenging long-term financial planning.
Tariff Impact
Potential tariff impacts could increase costs and reduce margins, posing a threat to competitive pricing and profitability in affected markets.

Vistance Networks (VISN) vs. SPDR S&P 500 ETF (SPY)

Vistance Networks Business Overview & Revenue Model

Company DescriptionGyroscope Therapeutics Holdings plc, a clinical-stage gene therapy company, through its subsidiaries, develops gene therapy products to treat patients with eye diseases. It focuses on developing a pipeline of recombinant adeno-associated virus vector-based gene therapy candidates targeting genetic variants in the complement pathway for age-related macular degeneration. The company is developing GT005, which is in Phase II clinical trials for the treatment of geographic atrophy secondary to age-related macular degeneration; and GT011, a preclinical recombinant adeno-associated virus gene therapy, for the treatment of geographic atrophy secondary to age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom.
How the Company Makes MoneyCommScope generates revenue through multiple streams, primarily by selling its products and services to telecommunications service providers, enterprises, and data centers. The company's revenue model includes the sale of hardware such as cables, antennas, and network equipment, as well as software solutions for network management and optimization. Significant partnerships with major telecommunications companies and collaborations on large-scale projects contribute to its earnings. Additionally, CommScope benefits from the ongoing demand for network upgrades and expansions, driven by the growth of data consumption and the rollout of next-generation wireless technologies like 5G.

Vistance Networks Financial Statement Overview

Summary
CommScope Holding shows a mixed financial performance. The income statement indicates strong recovery and profitability in the TTM period, but historical volatility raises concerns. The balance sheet reflects high leverage and financial instability, while cash flow shows improvement but with potential volatility. Overall, the company faces challenges in maintaining consistent financial health.
Income Statement
CommScope Holding's income statement shows a strong recovery in the TTM period with a significant revenue growth rate of 11.52% and a net profit margin of 19.63%. The gross profit margin improved to 41.11%, indicating efficient cost management. However, historical data reveals volatility with negative net income in previous years, highlighting potential risks in maintaining profitability.
Balance Sheet
The balance sheet reflects high leverage with a negative stockholders' equity, resulting in an unfavorable debt-to-equity ratio of -6.81 in the TTM period. This indicates financial instability and potential risk in meeting long-term obligations. The return on equity is negative, further emphasizing the challenges in generating returns for shareholders.
Cash Flow
Cash flow analysis shows a positive trend with a 7.9% growth in free cash flow in the TTM period. The operating cash flow to net income ratio is 0.26, indicating moderate cash generation relative to net income. However, historical fluctuations in free cash flow growth suggest potential volatility in cash flow management.
Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Vistance Networks Technical Analysis

Technical Analysis Sentiment
Positive
Last Price19.58
Price Trends
50DMA
18.17
Positive
100DMA
17.02
Positive
200DMA
12.09
Positive
Market Momentum
MACD
0.12
Negative
RSI
62.19
Neutral
STOCH
83.35
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For VISN, the sentiment is Positive. The current price of 19.58 is above the 20-day moving average (MA) of 18.33, above the 50-day MA of 18.17, and above the 200-day MA of 12.09, indicating a bullish trend. The MACD of 0.12 indicates Negative momentum. The RSI at 62.19 is Neutral, neither overbought nor oversold. The STOCH value of 83.35 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VISN.

Vistance Networks Risk Analysis

Vistance Networks disclosed 46 risk factors in its most recent earnings report. Vistance Networks reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Vistance Networks Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$4.03B274.432.13%15.60%
70
Outperform
$4.60B21.1118.41%0.17%13.42%31.28%
68
Neutral
$1.57B39.386.71%1.46%78.77%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
60
Neutral
$4.22B-156.029.86%99.11%
59
Neutral
$2.09B254.3317.08%14.31%
58
Neutral
$6.12B-456.72-7.49%4.24%-141.83%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
VISN
Vistance Networks
19.58
14.19
263.27%
BDC
Belden
117.89
0.74
0.63%
DGII
Digi International
42.73
12.53
41.49%
EXTR
Extreme Networks
16.06
-1.43
-8.18%
VIAV
Viavi Solutions
17.80
7.66
75.54%
PI
IMPINJ
181.36
44.84
32.85%

Vistance Networks Corporate Events

Business Operations and Strategy
CommScope Holding Relocates Headquarters to Texas
Neutral
Nov 3, 2025

On November 1, 2025, CommScope Holding Company, Inc. relocated its corporate headquarters to Richardson, Texas. This move signifies a strategic operational change for the company, potentially impacting its logistical and business operations.

The most recent analyst rating on (COMM) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on CommScope Holding stock, see the COMM Stock Forecast page.

M&A TransactionsShareholder Meetings
CommScope Approves Sale of Connectivity Segment
Neutral
Oct 16, 2025

On October 16, 2025, CommScope Holding Company, Inc. announced that its stockholders approved the sale of its Connectivity and Cable Solutions segment to Amphenol Corporation. This decision was made during a special stockholders meeting, where the majority of the company’s stockholders voted in favor of the transaction. Additionally, stockholders approved advisory compensation related to the sale and deemed it unnecessary to adjourn the meeting for further votes. This transaction marks a significant shift in CommScope’s operations, potentially impacting its market positioning and stakeholder interests.

The most recent analyst rating on (COMM) stock is a Hold with a $16.50 price target. To see the full list of analyst forecasts on CommScope Holding stock, see the COMM Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 26, 2025